Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today a new research collaboration with Prof.
Globally, about 1 in 6 deaths is due to cancer. With advances in treatment, early detection and treatment of cancer greatly improves survival rates of patients.
Quanterix Corporation (NASDAQ:QTRX),today announced a collaboration with DestiNA Genomics, a manufacturer of patented reagents for nucleic acid detection
The research was funded by Pathway to Independence, the Purdue Centre for Cancer Research, the Indiana Clinical and Translational Sciences Institute and the National Centre for Advancing Translational Sciences